HIV prevention injection successful in South Africa trial

allafrica.com

A pivotal trial in South Africa showed a highly effective HIV prevention injection, lenacapavir, providing six months of protection per shot. The injection outperformed prevention pills, with 0 new HIV infections in the lenacapavir group. Concerns remain about access and pricing, with hopes for quicker availability than previous treatments. Gilead aims to expedite regulatory approval and licensing for broader access.


With a significance score of 5.2, this news ranks in the top 0.8% of today's 23358 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


HIV prevention injection successful in South Africa trial | News Minimalist